Argus raised the firm’s price target on Boston Scientific (BSX) to $130 from $105 and keeps a Buy rating on the shares. The firm sees strong ...
In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Boston Scientific (BSX – Research Report), with a ...
Boston University researchers created a droplet microfluidic component library, enabling quick and affordable device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback